Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study
Fetal Diagnosis and Therapy · 2024
DOI: 10.1159/000542147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2024. Verfasst von Lizhong Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou,…. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Microarray Analysis, Chromosome Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
Chromosomal microarray analysis (CMA) can identify clinically significant microdeletions and microduplications, providing valuable insights into the genetic basis of various disorders. Our study was to evaluate clinical management and prognosis of fetuses with prenatal variants of unknown significance (VOUS) and determine diagnostic approaches for subsequent pregnancies.
Methods
This study included 2,953 fetuses undergoing CMA at the Prenatal Diagnostic Center of Changzhou Maternal and Child Health Care Hospital from January 2018 to December 2022, identifying 162 cases with VOUS. Parent-of-origin testing determined the origin of copy number variations. Prenatal genetic counseling was provided, and outcomes were followed for 3–36 months post-birth.
Results
All 162 VOUS cases received prenatal genetic counseling. Among these, 123 continued the pregnancy; 22 chose termination, and 17 were lost to follow-up. Of the continuations, 116 delivered at term and 7 preterm. Post-birth follow-up showed 5/123 live-born fetuses developed relevant clinical phenotypes. Parent-of-origin testing in 21 cases identified 18 hereditary and 3 de novo variants. Additionally, five subsequent pregnancies were monitored, with two undergoing amniocentesis and three receiving low-risk noninvasive prenatal testing, all with positive outcomes.
Conclusion
VOUS, occurring in approximately 5% of cases, require comprehensive prenatal genetic counseling and show generally favorable outcomes. Despite low association with adverse clinical phenotypes, the importance of postnatal follow-up and regular report updates is emphasized to detect potential clinical associations early.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou, China.
Zitieren
APA
Yin, L., Wang, J., Zhang, B., Wang, W., & Yu, B. (2024). Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000542147
Vancouver
Yin L, Wang J, Zhang B, Wang W, Yu B. Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study. Fetal Diagnosis and Therapy. 2024. doi:10.1159/000542147
BibTeX
@article{Yin2024,
author = {Yin, Lizhong and Wang, Jing and Zhang, Bin and Wang, Wenli and Yu, Bin},
title = {Postnatal Outcomes of Fetal Variants of Unknown Significance in Prenatal Chromosomal Microarray Analysis: A Single-Center Study},
journal = {Fetal Diagnosis and Therapy},
year = {2024},
doi = {10.1159/000542147}
}
EUVIMED